Add to favorites:
Share:
This funding call focuses on innovations using genetically engineered microbes for precision fermentation to transform CO2 into valuable nutrients. It aligns with the Food 2030 R&I initiative and the EU's strategic goals for safer, sustainable food systems while fostering EU leadership in biotechnological advancements. The call promotes scaling up biotechnological processes, fostering start-up companies, and improving pilot plants in Europe to increase nutrient production efficiency.
Key activities include analyzing costs and investments for scaling up microbe-based nutrient production, developing sustainable business models, evaluating environmental and economic impacts, and creating open-space databases to facilitate industry adoption. It supports collaboration with SMEs, start-ups, and regional innovation projects, aiming to establish shared infrastructures for pre-commercialization testing. Additionally, international cooperation, especially with the US, is encouraged to maximize global impact.
Opening: 06-05-2025
Deadline(s): 04-09-2025
Data provided by Ghent University
This funding opportunity represents a pre-agreed draft that has not yet been officially approved by the European Commission. The final, approved version is expected to be published in the first quarter of 2025. This draft is provided for informational purposes and may be used to preliminarily form consortia and develop project ideas, but it is offered without any guarantees or warranties.
Expected Outcome
• Improved cost and resource-efficiency analysis of bioreactors.
• Enhanced understanding of environmental impacts from CO2 reduction.
• Development of infrastructure for testing and implementing biotechnology.
• Scale-up of innovative technologies for CO2-to-nutrient conversion.
• Improved pilot plants to support nutrient production and scaling.
Scope
• Analyze costs and investments for scaling up biotechnology using genetically engineered microbes.
• Establish business models for precision fermentation and industry applications, including databases for pre-commercial testing.
• Evaluate the environmental, economic, and sustainability impacts of biotechnological processes.
• Scale up feasibility analysis for developed biotechnologies, focusing on removing barriers.
• Foster collaboration among SMEs, start-ups, and regional innovation hubs.